Aldwych Partners advised on the competition risks associated with a planned acquisition of a major portfolio of care homes. Based on our advice, the transaction was structured to exclude those homes with the highest risk of an adverse finding by the CMA, and was subsequently cleared by the CMA at Phase 1. The parties were able to complete the transaction without any requirement for interim measures or divestment.
Mental health: unintended effects of limiting out of area placements?
NHS mental health trusts could, according to a report in HSJ, face regulatory action for not…Read more